A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency

Ann Allergy Asthma Immunol. 2021 Jan;126(1):90-92. doi: 10.1016/j.anai.2020.08.017. Epub 2020 Aug 18.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Adult
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use
  • Asthma / immunology*
  • Asthma / pathology
  • Asthma / therapy
  • Asthma / virology
  • COVID-19 / immunology*
  • COVID-19 / pathology
  • COVID-19 / therapy
  • COVID-19 / virology
  • COVID-19 Serotherapy
  • Common Variable Immunodeficiency / immunology*
  • Common Variable Immunodeficiency / pathology
  • Common Variable Immunodeficiency / therapy
  • Common Variable Immunodeficiency / virology
  • Fatal Outcome
  • Humans
  • IgG Deficiency / immunology*
  • IgG Deficiency / pathology
  • IgG Deficiency / therapy
  • IgG Deficiency / virology
  • Immunization, Passive
  • Immunoglobulin G / blood
  • Immunoglobulins, Intravenous / therapeutic use
  • Male
  • Methicillin-Resistant Staphylococcus aureus
  • Obesity, Morbid / immunology*
  • Obesity, Morbid / pathology
  • Obesity, Morbid / therapy
  • Obesity, Morbid / virology
  • SARS-CoV-2
  • Staphylococcal Infections / immunology*
  • Staphylococcal Infections / pathology
  • Staphylococcal Infections / therapy
  • Staphylococcal Infections / virology

Substances

  • Antiviral Agents
  • Immunoglobulin G
  • Immunoglobulins, Intravenous
  • remdesivir
  • Adenosine Monophosphate
  • Alanine